Faculty Opinions recommendation of Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma.

2009 ◽  
Author(s):  
Paul Nghiem ◽  
Kelly Paulson
Keyword(s):  
Phase I ◽  
Metastatic Melanoma ◽  
Phase I Trial ◽  
Interleukin 12

Analysis of patient survival in a Phase I trial of systemic targeted α-therapy for metastatic melanoma

Immunotherapy ◽  
2011 ◽  
Vol 3 (9) ◽  
pp. 1041-1050 ◽  
Author(s):  
Barry J Allen ◽  
Apresh A Singla ◽  
Syed M Abbas Rizvi ◽  
Peter Graham ◽  
Frank Bruchertseifer ◽  
...  
Keyword(s):  
Phase I ◽  
Metastatic Melanoma ◽  
Phase I Trial ◽  
Patient Survival

scholarly journals Safety and Clinical Effect of Subcutaneous Human Interleukin-21 in Patients with Metastatic Melanoma or Renal Cell Carcinoma: A Phase I Trial

2010 ◽  
Vol 16 (21) ◽  
pp. 5312-5319 ◽  
Author(s):  
Henrik Schmidt ◽  
Janet Brown ◽  
Ulrik Mouritzen ◽  
Peter Selby ◽  
Kirsten Fode ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Phase I ◽  
Cell Carcinoma ◽  
Metastatic Melanoma ◽  
Renal Cell ◽  
Phase I Trial ◽  
Clinical Effect ◽  
Interleukin 21

Phase I trial of imatinib and temozolomide in patients with metastatic melanoma

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 7572-7572 ◽  
Author(s):  
L. Schuchter ◽  
K. Flaherty ◽  
R. Davidson ◽  
L. Cavallaro ◽  
M. Hendricks ◽  
...  
Keyword(s):  
Phase I ◽  
Metastatic Melanoma ◽  
Phase I Trial

scholarly journals A phase I trial of paclitaxel and trastuzumab in combination with interleukin-12 in patients with HER2/neu-expressing malignancies

2009 ◽  
Vol 8 (11) ◽  
pp. 2983-2991 ◽  
Author(s):  
Tanios S. Bekaii-Saab ◽  
Julie M. Roda ◽  
Kristan D. Guenterberg ◽  
Bhuvanaswari Ramaswamy ◽  
Donn C. Young ◽  
...  
Keyword(s):  
Phase I ◽  
Phase I Trial ◽  
Interleukin 12

scholarly journals Phase I trial of biochemotherapy with cisplatin, temozolomide, and dose escalation of nab-paclitaxel combined with interleukin-2 and interferon-α in patients with metastatic melanoma

2014 ◽  
Vol 24 (4) ◽  
pp. 342-348 ◽  
Author(s):  
Anas Alrwas ◽  
Nicholas E. Papadopoulos ◽  
Suzanne Cain ◽  
Sapna P. Patel ◽  
Kevin B. Kim ◽  
...  
Keyword(s):  
Phase I ◽  
Metastatic Melanoma ◽  
Dose Escalation ◽  
Phase I Trial ◽  
Interleukin 2 ◽  
Interferon Α

scholarly journals Safety, Clinical Activity, and Biological Correlates of Response in Patients with Metastatic Melanoma: Results from a Phase I Trial of Atezolizumab

2019 ◽  
Vol 25 (20) ◽  
pp. 6061-6072 ◽  
Author(s):  
Omid Hamid ◽  
Luciana Molinero ◽  
Christopher R. Bolen ◽  
Jeffrey A. Sosman ◽  
Eva Muñoz-Couselo ◽  
...  
Keyword(s):  
Phase I ◽  
Metastatic Melanoma ◽  
Phase I Trial ◽  
Clinical Activity

Phase I Trial of Cisplatin, WR-2721, and the Murine Monoclonal Antibody R24 in Patients with Metastatic Melanoma

1994 ◽  
Vol 15 (4) ◽  
pp. 273-282 ◽  
Author(s):  
R. M. Bukowski ◽  
S. A. Murthy ◽  
J. Finke ◽  
M. J. Caulfield ◽  
R. Tubbs ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Phase I ◽  
Metastatic Melanoma ◽  
Phase I Trial ◽  
Murine Monoclonal Antibody

A Phase I Trial with a Hybrid Cell Vaccine in Patients with Metastatic Melanoma

1998 ◽  
pp. 519-525 ◽  
Author(s):  
U. Trefzer ◽  
G. Weingart ◽  
Y. Chen ◽  
K. Adrian ◽  
H. Audring ◽  
...  
Keyword(s):  
Phase I ◽  
Metastatic Melanoma ◽  
Phase I Trial ◽  
Hybrid Cell ◽  
Cell Vaccine

scholarly journals Phase I trial of interferon-γ (IFN-γ) retroviral vector administered intratumorally to patients with metastatic melanoma

1999 ◽  
Vol 6 (4) ◽  
pp. 322-330 ◽  
Author(s):  
John Nemunaitis ◽  
Timothy Fong ◽  
Joan M Robbins ◽  
Gerald Edelman ◽  
Wilson Edwards ◽  
...  
Keyword(s):  
Phase I ◽  
Metastatic Melanoma ◽  
Phase I Trial ◽  
Interferon Γ ◽  
Retroviral Vector ◽  
Ifn Γ

A phase I trial of an interleukin‐12/23 monoclonal antibody in relapsing multiple sclerosis

2006 ◽  
Vol 22 (9) ◽  
pp. 1671-1678 ◽  
Author(s):  
Lloyd H. Kasper ◽  
Daniel Everitt ◽  
Thomas P. Leist ◽  
Kathleen A. Ryan ◽  
Mary Ann Mascelli ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Monoclonal Antibody ◽  
Phase I ◽  
Phase I Trial ◽  
Interleukin 12 ◽  
Relapsing Multiple Sclerosis
Sign in / Sign up

Export Citation Format

Share Document